Research Article
TREM-1 and TREM-2 Expression on Blood Monocytes Could Help Predict Survival in High-Grade Glioma Patients
Table 1
Characteristics of glioma patients.
| Patients | No. | |
| All gliomas | 63 | | Sex (male/female) | 38/25 | | Grades (male/female) | | | G. II | 14/5 | 14/5 () | G. II-III | 2/0 | 2/0 (30.5) | G. III | 7/4 | 7/4 () | G. III-IV | 0/1 | 0/1 (55) | G. IV | 15/15 | 15/15 () | Primary diagnosis | 49 | | Relapse | 13 | | Unknown | 1 | | Diagnosis | | | Diffuse glioma II | 4 | | Oligodendroglioma II | 7 | | Oligoastrocytoma II | 1 | | Astrocytoma II | 7 | | Oligodendroglioma II-III | 1 | | Astrocytoma II-III | 1 | | Anaplastic astrocytoma | 11 | | Anaplastic astrocytoma with signs of GBM | 1 | | Primary GBM | 28 | | Unknown GBM | 2 | | Completely resected | | | G. II | 4 | | G. II-III | 0 | | G. III | 3 | | G. III-IV | 0 | | G. IV | 4 | | IDH1/2 mutated | 25 | | G. II, III | 24 | | G. IV | 1 | | Steroid treated/untreated | | | G. II | 7/12 | | G. III | 9/4 | | G. IV | 28/3 | |
|
|
No.: number of patients; G.: grade; GBM: glioblastoma multiforme; IDH: isocitrate dehydrogenase.
|